AI Articles and Analysis about Enterprise resource planning

Where new, emerging capabilities in AI mean new opportunities for financial institutions – especially those that operate financial exchanges, where data and predictive analytics are paramount – the palpable risk of failure in AI adoption initiatives can prove a significant hurdle. 

Humana Inc. is the fourth most significant health insurance provider in the U.S. Founded in 1961, Humana is based in Louisville, Kentucky. Humana was ranked 42 on the Fortune 500 list in 2023. Humana employs over 67,000 individuals and is one of the most prominent publicly traded managed care companies in the U.S. 

Zurich Insurance Group is a multi-line insurer serving over 55 million customers in more than 210 countries and territories. The company offers various property, casualty, and life insurance products and services. Founded in 1872, Zurich Insurance Group is headquartered in Zurich, Switzerland. In 2023, the Zurich Insurance Group reported business operating profits of 7.4 billion USD, an increase of 21% from 2022. 

AI and machine learning are propelling the insurance sector forward – willingly or unwillingly – while offering organizations the ability to make substantial improvements. The technologies can help to enhance customer service, claims processing, fraud detection, and much more. They also potentially transform underwriting, risk assessment, and personalized pricing.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

AI and data science have seen increased use in life sciences, particularly in the pharmaceutical industry. However, despite the multitude of AI use cases, pharmaceutical companies tend not to embrace every emerging AI trend eagerly. 

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.